ArticleEuropean journal of clinical pharmacology2011

PK/PD modeling of rabeprazole in CYP2C19 genotypes: consideration of the influence of thio-ether metabolite, CYP3A4, accumulation and CYP2D6 polymorphism may help to better develop and validate the model.

Nuggehally R SrinivasPubMed ↗Publisher ↗

No numbers read from the abstract.